Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 7
1987 7
1988 7
1989 6
1990 7
1991 5
1992 5
1993 6
1994 10
1995 7
1996 5
1997 9
1998 5
1999 5
2000 10
2001 16
2002 11
2003 10
2004 8
2005 8
2006 10
2007 10
2008 7
2009 9
2010 7
2011 7
2012 11
2013 16
2014 11
2015 15
2016 18
2017 11
2018 5
2019 8
2020 12
2021 14
Text availability
Article attribute
Article type
Publication date

Search Results

301 results
Results by year
Filters applied: . Clear all
Page 1
Zuclopenthixol.
[No authors listed] [No authors listed] 2021 Feb 15. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2021 Feb 15. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 30000827 Free Books & Documents. Review.
Zuclopenthixol is not approved for marketing in the United States, by the U.S. ...One international guideline recommends that women taking zuclopenthixol not breastfeed.[1] However, a safety scoring system finds zuclopenthixol possible to use cautiously durin
Zuclopenthixol is not approved for marketing in the United States, by the U.S. ...One international guideline recommends that women t
Zuclopenthixol versus placebo for schizophrenia.
Lacey M, Jayaram MB. Lacey M, et al. Cochrane Database Syst Rev. 2015 Dec 1;(12):CD010598. doi: 10.1002/14651858.CD010598.pub2. Cochrane Database Syst Rev. 2015. PMID: 26624987 Review.
BACKGROUND: Zuclopenthixol is an older antipsychotic that has three distinct formulations (zuclopenthixol dihydrochloride, zuclopenthixol acetate or Acuphase and zuclopenthixol decanoate). ...We were only able to find short-term data and only trials ra …
BACKGROUND: Zuclopenthixol is an older antipsychotic that has three distinct formulations (zuclopenthixol dihydrochloride, …
Zuclopenthixol dihydrochloride for schizophrenia.
Bryan EJ, Purcell MA, Kumar A. Bryan EJ, et al. Cochrane Database Syst Rev. 2017 Nov 16;11(11):CD005474. doi: 10.1002/14651858.CD005474.pub2. Cochrane Database Syst Rev. 2017. PMID: 29144549 Free PMC article. Review.
BACKGROUND: Oral zuclopenthixol dihydrochloride (Clopixol) is an anti-psychotic treatment for people with psychotic symptoms, especially those with schizophrenia. ...Zuclopenthixol dihydrochloride (cis z isomer) versus zuclopenthixol (cis z/trans e isomer)The …
BACKGROUND: Oral zuclopenthixol dihydrochloride (Clopixol) is an anti-psychotic treatment for people with psychotic symptoms, especia …
Zuclopenthixol dihydrochloride for schizophrenia.
Kumar A, Strech D. Kumar A, et al. Schizophr Bull. 2009 Sep;35(5):855-6. doi: 10.1093/schbul/sbp077. Epub 2009 Aug 6. Schizophr Bull. 2009. PMID: 19661197 Free PMC article. Review. No abstract available.
Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses.
Coutinho E, Fenton M, Quraishi S. Coutinho E, et al. Cochrane Database Syst Rev. 2000;1999(2):CD001164. doi: 10.1002/14651858.CD001164. Cochrane Database Syst Rev. 2000. PMID: 10796607 Free PMC article. Review.
Where possible the number needed to treat (NNT) and its 95% confidence interval was also calculated. MAIN RESULTS: Four studies relating to zuclopenthixol decanoate were included. All compared zuclopenthixol decanoate with other depot preparations. Zuclopenthixol
Where possible the number needed to treat (NNT) and its 95% confidence interval was also calculated. MAIN RESULTS: Four studies relating to …
Zuclopenthixol dihydrochloride for schizophrenia.
Kumar A, Strech D. Kumar A, et al. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005474. doi: 10.1002/14651858.CD005474. Cochrane Database Syst Rev. 2005. PMID: 16235403 Updated. Review.
Ten short trials (total n=478) compared zuclopenthixol with other typical antipsychotics. Risk of being unchanged or worse was decreased by allocation to zuclopenthixol (n=357, 7 RCTs, RR 0.72 CI 0.53 to 0.98, NNT 10 CI 6 to 131). ...Three short trials (total n=233) …
Ten short trials (total n=478) compared zuclopenthixol with other typical antipsychotics. Risk of being unchanged or worse was decrea …
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis.
Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, Arndt T, Bäckers L, Rothe P, Cipriani A, Davis J, Salanti G, Leucht S. Huhn M, et al. Lancet. 2019 Sep 14;394(10202):939-951. doi: 10.1016/S0140-6736(19)31135-3. Epub 2019 Jul 11. Lancet. 2019. PMID: 31303314 Free PMC article.
Risk ratios compared with placebo for all-cause discontinuation (42 672 participants) ranged from 052 (012 to 095; clopenthixol) to 115 (036 to 147; pimozide), for sedation (30 770 participants) from 092 (017 to 203; pimozide) to 1020 (472 to 2941; zuclopenthixol), for use …
Risk ratios compared with placebo for all-cause discontinuation (42 672 participants) ranged from 052 (012 to 095; clopenthixol) to 115 (036 …
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.
Jayakody K, Gibson RC, Kumar A, Gunadasa S. Jayakody K, et al. Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD000525. doi: 10.1002/14651858.CD000525.pub3. Cochrane Database Syst Rev. 2012. PMID: 22513898 Free PMC article. Review.
One study reported no difference in adverse effects and outcome scores, when high dose (50-100 mg/injection) zuclopenthixol acetate was compared with low dose (25-50 mg/injection) zuclopenthixol acetate. ...Use of zuclopenthixol acetate may result in less num …
One study reported no difference in adverse effects and outcome scores, when high dose (50-100 mg/injection) zuclopenthixol acetate w …
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.
Gibson RC, Fenton M, Coutinho ES, Campbell C. Gibson RC, et al. Cochrane Database Syst Rev. 2004;(3):CD000525. doi: 10.1002/14651858.CD000525.pub2. Cochrane Database Syst Rev. 2004. PMID: 15266432 Updated. Review.
Compared with haloperidol or clotiapine, people allocated zuclopenthixol did not seem to be at more risk of a range of movement disorders (<20%). ...Similarly dizziness was equally infrequent for those allocated zuclopenthixol acetate compared with haloperidol (n …
Compared with haloperidol or clotiapine, people allocated zuclopenthixol did not seem to be at more risk of a range of movement disor …
Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses.
Fenton M, Coutinho ES, Campbell C. Fenton M, et al. Cochrane Database Syst Rev. 2001;(3):CD000525. doi: 10.1002/14651858.CD000525. Cochrane Database Syst Rev. 2001. PMID: 11686965 Updated. Review.
There is one oral preparation and two depot forms: zuclopenthixol acetate and zuclopenthixol decanoate. The acetate version does not stay in the body for very long (a single dose persists for only 72 hours) and is said to have these properties. ...Well-conducted ran …
There is one oral preparation and two depot forms: zuclopenthixol acetate and zuclopenthixol decanoate. The acetate version do …
301 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page